Howard Katzenstein, MD, currently serves as Executive Director of Scientific Affairs at Merck since April 2023 and as a Pediatric Oncologist at Nemours duPont Hospital for Children since February 2022. Katzenstein has held several prominent roles, including Medical Director of US Medical Affairs at EMD Serono, Inc. from February 2021 to January 2023, and Director of Pediatric Hematology/Oncology at Nemours from July 2017 to February 2021. Previous experience includes Medical Director of Pediatric Hematology/Oncology at Vanderbilt University Medical Center and Director of Clinical Research in Pediatric Hematology/Oncology at Children's Healthcare of Atlanta. Early career experience includes a position as a Physician at Ann & Robert H. Lurie Children's Hospital of Chicago. Academic qualifications include a Doctor of Medicine from the University of Illinois College of Medicine, a Pediatrics Residency Program at Children's Hospital of Pittsburgh, and a fellowship in Pediatric Hematology-Oncology from Northwestern University. Additionally, Katzenstein holds a Bachelor of Science in Bioengineering and Biomedical Engineering from the University of Illinois Urbana-Champaign.
This person is not in the org chart
This person is not in any teams
This person is not in any offices